Kevin Petrie
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Acute Myeloid Leukemia Research
Most-Cited Works
- → Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer(2005)1,902 cited
- → Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia(2012)652 cited
- → Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease(2014)207 cited
- → Differentiation therapy of acute myeloid leukemia: past, present and future(2009)160 cited
- → The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms(2003)141 cited
- → New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK(2013)132 cited
- → Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia–associated TEL-AML1 oncoprotein(2000)122 cited
- → Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity(2015)107 cited
- → Targeting of AML1-ETO in t(8;21) Leukemia by Oridonin Generates a Tumor Suppressor–Like Protein(2012)96 cited
- → Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer(2015)84 cited